XML 52 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Revenues $ 87,983 $ 84,944
Net investment income (loss) 454 334
Total revenues 88,437 85,278
Pharmacy    
Disaggregation of Revenue [Line Items]    
Revenues 48,397 52,785
Front Store    
Disaggregation of Revenue [Line Items]    
Revenues 5,370 5,597
Premiums    
Disaggregation of Revenue [Line Items]    
Revenues 30,391 24,352
Other    
Disaggregation of Revenue [Line Items]    
Revenues 3,825 2,210
Operating Segments | Health Care Benefits    
Disaggregation of Revenue [Line Items]    
Revenues 31,865 25,692
Net investment income (loss) 353 164
Total revenues 32,236 25,877
Operating Segments | Health Care Benefits | Pharmacy    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Operating Segments | Health Care Benefits | Front Store    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Operating Segments | Health Care Benefits | Premiums    
Disaggregation of Revenue [Line Items]    
Revenues 30,379 24,339
Operating Segments | Health Care Benefits | Other    
Disaggregation of Revenue [Line Items]    
Revenues 1,504 1,374
Operating Segments | Health Services    
Disaggregation of Revenue [Line Items]    
Revenues 36,466 40,811
Net investment income (loss) 0 0
Total revenues 40,285 44,591
Operating Segments | Health Services | Pharmacy network    
Disaggregation of Revenue [Line Items]    
Total revenues 20,464 27,592
Operating Segments | Health Services | Mail & specialty    
Disaggregation of Revenue [Line Items]    
Total revenues 17,262 16,145
Operating Segments | Health Services | Other    
Disaggregation of Revenue [Line Items]    
Total revenues 2,559 854
Operating Segments | Health Services | Pharmacy    
Disaggregation of Revenue [Line Items]    
Revenues 37,726 43,737
Operating Segments | Health Services | Front Store    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Operating Segments | Health Services | Premiums    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Operating Segments | Health Services | Other    
Disaggregation of Revenue [Line Items]    
Revenues 2,559 854
Operating Segments | Pharmacy & Consumer Wellness    
Disaggregation of Revenue [Line Items]    
Revenues 19,638 18,426
Net investment income (loss) 0 (3)
Total revenues 28,725 27,922
Operating Segments | Pharmacy & Consumer Wellness | Pharmacy    
Disaggregation of Revenue [Line Items]    
Revenues 22,784 21,780
Operating Segments | Pharmacy & Consumer Wellness | Front Store    
Disaggregation of Revenue [Line Items]    
Revenues 5,370 5,597
Operating Segments | Pharmacy & Consumer Wellness | Premiums    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Operating Segments | Pharmacy & Consumer Wellness | Other    
Disaggregation of Revenue [Line Items]    
Revenues 571 548
Corporate/ Other | Corporate/ Other    
Disaggregation of Revenue [Line Items]    
Revenues 14 15
Net investment income (loss) 101 173
Total revenues 115 188
Corporate/ Other | Corporate/ Other | Pharmacy    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Corporate/ Other | Corporate/ Other | Front Store    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Corporate/ Other | Corporate/ Other | Premiums    
Disaggregation of Revenue [Line Items]    
Revenues 12 13
Corporate/ Other | Corporate/ Other | Other    
Disaggregation of Revenue [Line Items]    
Revenues 2 2
Intersegment Eliminations    
Disaggregation of Revenue [Line Items]    
Net investment income (loss) 0 0
Total revenues (12,924) (13,300)
Intersegment Eliminations | Pharmacy    
Disaggregation of Revenue [Line Items]    
Revenues (12,113) (12,732)
Intersegment Eliminations | Front Store    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Intersegment Eliminations | Premiums    
Disaggregation of Revenue [Line Items]    
Revenues 0 0
Intersegment Eliminations | Other    
Disaggregation of Revenue [Line Items]    
Revenues $ (811) $ (568)